Neuroeconomics of Social Behavior Following Trauma Exposure
Study Details
Study Description
Brief Summary
This study will use a neuroeconomic paradigm with state-of-the-art imaging protocols to probe abnormal social reward processing underlying social withdrawal in symptomatic trauma-exposed women. By also gathering self-report measures of social anhedonia, performance on non-social and social reward valuation tasks, and measures of real-world social functioning including social network size, we aim to specify how alterations in social reward processing result in social withdrawal and functional impairment.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Impaired social functioning is a frequent and disabling sequela of trauma-related disorders. PTSD is associated with a high rate of severe impairment in quality of life relative to other anxiety disorders, including panic disorder, social phobia, and OCD, with particularly marked impairment in social quality of life. Mounting evidence indicates that impairment in quality of life in PTSD is strongly related to its effect on social functioning. Such difficulties are widespread and affect multiple social networks, including marital relationships, and friendships and family relationships. Social withdrawal, defined here in terms of reduced social network size, is of particular interest because of its strong relationship with health outcomes, including increased risk of disability, reduced immune response, and increased mortality risk; most critically, poor social integration is associated with a threefold increase in suicide risk. Because women are at a 2.3-to-3-fold increased risk compared to men of developing PTSD following trauma, understanding the differential neurobiological pathways that may contribute to the development of stress-related disorders in women is particularly critical. Women are more likely than men to endorse social detachment following trauma, especially when the trauma involves exposure to violence.
In this project, we propose abnormal reward processing (anhedonia) as a specific mechanism underlying social withdrawal in trauma-exposed women, and we present a paradigm that capitalizes on advances in neuroeconomics to elucidate the neural underpinnings of social withdrawal. Additionally, we propose to identify the possible influences of a stress peptide (pituitary adenylate cyclase-activating polypeptide: PACAP) implicated in sex-specific changes in social behavior following stress exposure.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Phase 1 Healthy control participants will provide neuroeconomic game responses to form a pool of potential responses for participants to interact with during Phase 2. |
|
Phase 2: PTS-SA posttraumatic spectrum-socially anhedonic |
|
Phase 2: PTS-nonSA posttraumatic spectrum-non-socially anhedonic |
|
Phase 2: HC healthy controls |
Outcome Measures
Primary Outcome Measures
- Group differences in neuroeconomic game performance [Measured on the day of the MRI scan]
Compared to the PTS-nonSA and HC groups, the PTS-SA group will demonstrate lower investments and slower learning rates on the Trust Task than on the non-social risk task compared with PTS-nonSA and HC subjects
- Group differences in fMRI BOLD signal [Measured on the day of the MRI scan]
The HC and PTS-nonSA groups will show greater ventral striatum (VS), dorsal striatum (DS), and medial prefrontal cortex (mPFC) responses during the outcome phase of the trust game for 'share' versus baseline, compared to the PTS-SA group, for the real partner condition (Trust Task), but not for the risk task.
- Correlations between behavior and fMRI BOLD signal [Measured on the day of the MRI scan]
Because social withdrawal will occur in response to reduced social reward value, we hypothesize that across the PTS groups, reduced VS, DS, and mPFC activity during the outcome phase of the trust game for 'share' outcomes will be associated with lower Trust Task investments, greater self-reported social anhedonia, and smaller social network size.
- PACAP correlations [Measured on the day of the MRI scan]
Elevated PACAP levels will be associated with lower investments on the Trust Task; decreased social reward signals during the outcome phase for 'share' outcomes in the VS, DS, and mPFC; and smaller social network size.
Secondary Outcome Measures
- Mediation analysis [Measured on the day of the MRI scan]
Within the PTS groups, decreased VS, DS, and mPFC response to 'share' outcomes will mediate the relationship between social anhedonia and reduced social network size.
- Functional connectivity (psychophysiological interaction) [Measured on the day of the MRI scan]
PTS individuals with higher self-reported social anhedonia and social withdrawal will show reduced VS-mPFC connectivity for social rewards on the Trust Task.
Eligibility Criteria
Criteria
Phase 1:
Inclusion Criteria:
-
Age 18-45
-
Self-reported healthy volunteer status
Exclusion Criteria:
-
Inability to provide written informed consent in English
-
Inability to see task due to visual impairment
-
Participants who produce T-scores of 65 or higher on any Brief Symptom Inventory (BSI) subscales will not be eligible to remain in the Trust Task participant pool.
Phase 2:
Inclusion Criteria:
-
Female
-
Trauma exposure appropriate to group
-
For trauma-exposed groups the index trauma is actual or threatened physical assault or sexual violence
-
PCL-5 score 33 and above (for PS-SA and PS-nonSA groups)
-
Right handedness
-
Age 18-45
-
English as a first language
Exclusion Criteria:
-
History of neurological illness (including head injury with loss of consciousness > 5 minutes)
-
Medical conditions that may influence neuroimaging (e.g. HIV)
-
Current or past DSM-5 Axis I disorder (for HC group)
-
History of bipolar disorder or schizophrenia spectrum disorder
-
Contraindications for MRI
-
Alcohol dependence in the past 5 years
-
Substance dependence in the past 3 years
-
Daily substance use in the past year
-
Prescribed psychotropic medication use in the past month
-
Wechsler Abbreviated Scale of Intelligence- Second Edition (WASI-II) FSIQ < 70.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | McLean Hospital | Belmont | Massachusetts | United States | 02478 |
Sponsors and Collaborators
- Mclean Hospital
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Elizabeth Olson, PhD, Mclean Hospital
Study Documents (Full-Text)
More Information
Publications
None provided.- 2017P001423
- K23MH112873-01A1